Clinical Trial Update: Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on Beta-1,3/1,6-D-Glucan Ganoderma Lucidum for non-infectious and idiopathic uveitis across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Beta-1,3/1,6-D-Glucan Ganoderma Lucidum (Beta-1,3/1,6-D-Glucan)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Uveitis | Phase 2, Phase 3 | Status: UNKNOWN